Skip to Page Content


*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.



The panel will deliberate about the benefits of using a low-carbohydrate or low-fat approach for diabetes treatment.


Disclosures (at time of recording):  

  • John Foreyt, PhD: Nothing to disclose

  • Kevin C. Maki, PhD, CLS, FNLA, FTOS: Kellogg: Advisory Board and Research; National Dairy Council: Advisory Board and Research; American Egg Board: Advisory Board and Research; National Cattleman’s Beef Association: Advisory Board and Research; Biofortis: Advisory Board

  • William S. Yancy, Jr., MD, MHS: NutriSystem: Advisory Board; Weight Watchers: Research; ViiV Healthcare: Spouse Part-time Employment


  • Eric C. Westman, MD, MHS: Vivus: Speakers Bureau; Eisai: Speakers Bureau; KE Diet: Advisory Board; Invoy: Advisory Board; Low Carbohydrate Ketogenic Diet Manual: Royalties; Cholesterol Clarity: Royalties; Keto Clarity: Royalties; Low Carb Adapt Website: Co-founder
  • Nothing to Disclose: Richard David Feinman, PhD; Dana Mansell, CHCP; William McCarthy, MD; Stacy Schmidt, PhD; Laurie Traetow, CAE


Presentation Information
Presentation Date:
March 29, 2017
Expiration Date:
December 31, 2020 11:55 PM
Presentation Objectives
  • Evaluate various dietary methods for attaining glycemic control.
Fat Restriction or Carbohydrate Restriction for the Treatment of Diabetes - Part 4: Panel Discussion
John Foreyt is Professor, Department of Medicine, at Baylor College of Medicine, Houston, Texas. He is Director of the DeBakey Heart Center's Behavioral Medicine Research Center, Department of Medicine, at Baylor. He has served as a member of the National Task Force on the Prevention and Treatment of Obesity, NIHI; The Committee to Develop Criteria for Evaluating Outcomes of Approaches to Prevent and Treat Obesity, Institute of Medicine, National Academy of Sciences; and The Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults, NIH. He has published 17 books and more than 380 articles in obesity, lifestyle modification, and related areas.

Kevin C. Maki, Ph.D. is the Founder and Chief Science Officer for the Midwest Center for Metabolic and Cardiovascular Research in Chicago, Illinois. Dr. Maki also holds an Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University. He earned a Ph.D. in Epidemiology from the University of Illinois at Chicago's School of Public Health, and an M.S. in Preventive and Rehabilitative Cardiovascular Health from Benedictine University. Dr. Maki has participated in more than 250 clinical trials and observational studies as an investigator, consultant or statistician, and published more than 250 scientific papers, books and book chapters.

Dr. Yancy, a general internist, is a Research Scientist in the Center for Health Services Research in Primary Care and a Staff Physician in Ambulatory Care at the Durham VA Medical Center. He is also an Associate Professor in the Department of Medicine at Duke University. He has research interests in the impact of obesity on health and health care, and in weight loss interventions used in primary care. His prior work has examined the relationship between obesity and use of clinical services. He has also performed a number of trials investigating the effects of various dietary and weight loss approaches on body weight, cardiovascular risk, and diabetes.
Individual topic purchase: Selected
Share This
Preview Fat Restriction or Carbohydrate Restriction for the Treatment of Diabetes - Part 4: Panel DiscussionPreview Fat Restriction or Carbohydrate Restriction for the Treatment of Diabetes - Part 4: Panel Discussion
All Access Subscription
Use for All Access  account holders only
To continue, you need to log in to oma. If you have any questions about your account please contact us at 1-866-702-3278.
Email Address:
OMA Member Price: